Artivion (AORT) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Artivion (AORT) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 17.54% |
| 10 | Artivion | 1.36 Bn | 1.28 Bn | 80.52 Mn | -58.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -58.67% |
| Mar 31, 2026 | 28.15% |
| Dec 31, 2025 | 3.80% |
| Sep 30, 2025 | 35.25% |
| Jun 30, 2025 | 32.30% |
| Mar 31, 2025 | 46.98% |
| Dec 31, 2024 | 6.40% |
| Sep 30, 2024 | -30.38% |
| Jun 30, 2024 | 0.88% |
| Mar 31, 2024 | 63.87% |
| Dec 31, 2023 | -4.75% |
| Sep 30, 2023 | -50.59% |
| Jun 30, 2023 | 2.85% |
| Mar 31, 2023 | -26.63% |
| Dec 31, 2022 | 74.81% |
| Sep 30, 2022 | -367.75% |
| Jun 30, 2022 | -51.89% |
| Mar 31, 2022 | -125.13% |
| Dec 31, 2021 | -195.88% |
| Sep 30, 2021 | 89.10% |